Public opinion regarding U.S. Food and Drug Administration approval of aducanumab and potential policy responses: A nationally representative survey.

"CONFLICT OF INTEREST Dr. Alexander is past Chair and a current member of FDA's Peripheral and Central Nervous System Advisory Committee; is a co‐founding Principal and equity holder in Monument Analytics, a health care consultancy whose clients include the life sciences industry as well as plaintiffs in opioid litigation; and is a member of OptumRx's National P&T Committee. These arrangements have been reviewed and approved by Johns Hopkins University in accordance with its conflict of interest policies. Dr. Polsky has provided consulting services for Extend Health. Drs. DiStefano and Anderson have no conflicts of interest to report."

"Funding information This work was funded by a grant from Arnold Ventures and the Hopkins Economics of Alzheimer's Disease and Services (HEADS) Center (P30 AG066587). The funders had no role in the design, methods, subject recruitment, data collections, analysis, or preparation of the paper."